US Broker Ratings

CONMED Corporation (CNMD) Stock Analysis: Navigating Potential in Medical Devices Amid Market Challenges

CONMED Corporation (NASDAQ: CNMD), a notable player in the healthcare sector specializing in medical devices, presents a compelling case for investors, even amidst a challenging market..

ARS Pharmaceuticals, Inc. (SPRY): An Investor Outlook on Potential 444.79% Upside

Investors in ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) have been keeping a close eye on this innovative biopharmaceutical company, which is making significant strides in the healthcare..

PACS Group, Inc. (PACS): An Investor’s Outlook on Healthcare’s Rising Star with a 37% Upside

PACS Group, Inc. (PACS), a prominent player in the healthcare sector specializing in medical care facilities, has been catching the eye of investors with its impressive..

NewAmsterdam Pharma (NAMS) Stock Analysis: Exploring a 114.68% Potential Upside in Biotech Innovation

Investors eyeing opportunities in the biotechnology sector may find NewAmsterdam Pharma Company N.V. (NAMS) an intriguing proposition. With a market capitalization of $2.82 billion, this Netherlands-based..

Phreesia, Inc. (PHR) Stock Analysis: Uncovering a 39.27% Upside Potential in Healthcare SaaS

Phreesia, Inc. (NYSE: PHR) is making waves in the healthcare sector with its innovative SaaS-based platform aimed at revolutionizing patient engagement and administrative processes for healthcare..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a Promising 18.64% Upside Potential

UFP Technologies, Inc. (NASDAQ: UFPT), a key player in the healthcare sector, has captured investor attention with its innovative solutions in the medical devices industry. Headquartered..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring a Potential 100% Upside Opportunity

For investors keeping a close eye on the biotechnology sector, Celldex Therapeutics, Inc. (NASDAQ: CLDX) presents an intriguing proposition. The company, headquartered in Hampton, New Jersey,..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: A 37.06% Upside in Precision Oncology

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stands at the forefront of precision medicine oncology, drawing keen interest from investors due to its promising therapeutic pipeline and a..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: Exploring a 63.81% Potential Upside in the Biotech Arena

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) stands out in the biotechnology sector with a promising range of RNA interference therapies targeting intractable diseases. The company’s innovative pipeline..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: Exploring a 43% Upside Potential Amid Innovative Biotech Advances

Scholar Rock Holding Corporation (NASDAQ: SRRK) is making waves in the healthcare sector, particularly within the biotechnology industry. As a company dedicated to pioneering treatments for..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Exploring a 115% Potential Upside in the Biotechnology Sector

Beam Therapeutics Inc. (NASDAQ: BEAM) stands out in the biotechnology sector with its ambitious pursuit of precision genetic medicines. Based in Cambridge, Massachusetts, this innovative company..

Sotera Health Company (SHC) Stock Analysis: Exploring a 23% Upside Potential in the Healthcare Sector

Sotera Health Company (SHC), a prominent player in the healthcare sector’s diagnostics and research industry, is garnering attention with its robust market position and potential upside...

Adaptive Biotechnologies Corp (ADPT): Investor Outlook on a Healthcare Innovator with Promising Growth Potential

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) stands at the forefront of innovation in the healthcare sector, specifically within the Diagnostics & Research industry. Headquartered in Seattle, Washington,..

Immunocore Holdings plc (IMCR) Stock Analysis: Unpacking a 103.98% Potential Upside

Investors with a keen eye on the biotechnology sector should take a closer look at Immunocore Holdings plc (NASDAQ: IMCR), a UK-based biopharmaceutical company specializing in..

BGM Group Ltd. (BGM): Valuation Insights for Investors Amidst Rapid Revenue Growth

BGM Group Ltd. (BGM), a Chinese pharmaceutical and chemical company, has recently attracted the attention of investors and analysts alike due to its impressive revenue growth...

Certara, Inc. (CERT) Stock Analysis: Navigating Healthcare Tech with a Cautious Outlook

Certara, Inc. (NASDAQ: CERT) operates at the intersection of healthcare and technology, specializing in biosimulation to aid drug discovery and development processes. With a market capitalization..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring a 19.34% Potential Upside in the Volatile Health Information Services Sector

GoodRx Holdings, Inc. (NASDAQ: GDRX) is a prominent player in the healthcare sector, specifically within the health information services industry. Headquartered in Santa Monica, California, the..

PTC Therapeutics, Inc. (PTCT): Investor Outlook on a Biotech Innovator Poised for 54% Upside

PTC Therapeutics, Inc. (NASDAQ: PTCT) presents a compelling opportunity for investors with a keen interest in the biotechnology sector, particularly those focused on companies pioneering treatments..

Xenon Pharmaceuticals Inc. (XENE): Investor Outlook with a 102% Potential Upside

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a neuroscience-focused biopharmaceutical company headquartered in Burnaby, Canada, is capturing the attention of investors with its promising pipeline and significant growth..

Bausch Health Companies Inc. (BHC) Stock Analysis: Evaluating a 29.98% Potential Upside in the Healthcare Sector

Bausch Health Companies Inc. (NYSE: BHC), a prominent player in the healthcare sector, presents an intriguing investment opportunity with a potential upside of 29.98%. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds